Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gamino Peña ME"'
Publikováno v:
International journal of clinical pharmacology and therapeutics. 53(10)
OBJECTIVE The oral retinoid agent isotretinoin (13-cis-retinoic acid) is approved for the treatment of severe recalcitrant cystic acne. For registrational renewal of Oratane® in Mexico (isotretinoin; Laboratorios Dermatologicos Darier S.A. de C.V.,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7480e792f8da127c321deb68e0ef43fa
https://pubmed.ncbi.nlm.nih.gov/26308169
https://pubmed.ncbi.nlm.nih.gov/26308169
Autor:
Gómez-Silva M; Forensic Medicine Service, School of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon, Mexico.; Analytical Department of the Research Institute for Clinical and Experimental Pharmacology, Ipharma S.A, Monterrey, Nuevo Leon, Mexico., Piñeyro-Garza E; Clinical Department of the Research Institute for Clinical and Experimental Pharmacology, Ipharma S.A, Monterrey, Nuevo Leon, Mexico., Vargas-Zapata R; Quality Assurance Department of the Research Institute for Clinical and Experimental Pharmacology, Ipharma S.A, Monterrey, Nuevo Leon, Mexico., Gamino-Peña ME; Statistical Department of the Research Institute for Clinical and Experimental Pharmacology, Ipharma S.A, Monterrey, Nuevo Leon, Mexico., León-García A; Pharmaceutical Research S.A, Mexico City, CDMX, Mexico., de León MB; Department of Molecular Biology, Center for Biomedical Research of the Northeast, Mexican Institute of Social Security, Monterrey, Nuevo Leon, Mexico., Llerena A; Clinical Research Center of Health Area, Hospital and Medical School of Extremadura University, Badajoz, Spain., León-Cachón RBR; Center of Molecular Diagnostics and Personalized Medicine, Department of Basic Sciences, Division of Health Sciences, University of Monterrey, San Pedro Garza Garcia, Nuevo Leon, Mexico. rafael.reyesleon@udem.edu.
Publikováno v:
Scientific reports [Sci Rep] 2019 Nov 28; Vol. 9 (1), pp. 17833. Date of Electronic Publication: 2019 Nov 28.
Autor:
León-Cachón RBR; Centro de Diagnóstico Molecular y Medicina Personalizada, Departamento de Ciencias Básicas, División Ciencias de la Salud, Universidad de Monterrey, San Pedro Garza García, NL, México.; Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, NL, México., Ascacio-Martínez JA; Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, NL, México., Gamino-Peña ME; Ipharma S.A., Monterrey, NL, México., Cerda-Flores RM; Facultad de Enfermería, Universidad Autónoma de Nuevo León, Monterrey, NL, México., Meester I; Centro de Diagnóstico Molecular y Medicina Personalizada, Departamento de Ciencias Básicas, División Ciencias de la Salud, Universidad de Monterrey, San Pedro Garza García, NL, México., Gallardo-Blanco HL; Departamento de Genética, Universidad Autónoma de Nuevo León, Monterrey, NL, México., Gómez-Silva M; Ipharma S.A., Monterrey, NL, México., Piñeyro-Garza E; Ipharma S.A., Monterrey, NL, México., Barrera-Saldaña HA; Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, NL, México. habarrera@gmail.com.; Vitagénesis S.A., Monterrey, NL, México. habarrera@gmail.com.
Publikováno v:
BMC cancer [BMC Cancer] 2016 Feb 08; Vol. 16, pp. 74. Date of Electronic Publication: 2016 Feb 08.
Publikováno v:
International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2015 Oct; Vol. 53 (10), pp. 897-904.
Autor:
Piñeyro-López A; Ipharma SA de CV, Monterrey, México. bioequilvalencia@i-pharma.com.mx, Piñeyro-Garza E, Gómez-Silva M, Reyes-Araiza R, Flores-Diego MA, Borrego-Alvarado S, Gamino-Peña ME, Vargas-Zapata R, Salazar-Leal ME
Publikováno v:
Clinical therapeutics [Clin Ther] 2009 Feb; Vol. 31 (2), pp. 411-7.